Piramal Pharma zooms on reporting over 4-fold jump in Q2 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Piramal Pharma is currently trading at Rs. 246.00, up by 29.30 points or 13.52% from its previous closing of Rs. 216.70 on the BSE.
The scrip opened at Rs. 227.90 and has touched a high and low of Rs. 246.70 and Rs. 224.05 respectively. So far 1237407 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 248.50 on 24-Sep-2024 and a 52 week low of Rs. 87.55 on 26-Oct-2023.
Last one week high and low of the scrip stood at Rs. 248.50 and Rs. 209.45 respectively. The current market cap of the company is Rs. 32321.74 crore.
The promoters holding in the company stood at 34.95%, while Institutions and Non-Institutions held 45.53% and 19.52% respectively.
Piramal Pharma has reported over 2-fold jump in its net profit at Rs 210.06 crore for second quarter ended September 30, 2024 (Q2FY25) as compared to Rs 77.16 crore for the same quarter in the previous year. Total income of the company increased by 28.38% at Rs 1,390.77 crore for Q2FY25 as compared to Rs 1,083.32 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported over 4-fold jump in net profit at Rs 22.59 crore for Q2FY25 as compared to Rs 5.02 crore for the same quarter in the previous year. Total income of the company increased by 17.46% at Rs 2302.86 crore for Q2FY25 as compared to Rs 1960.57 crore for the corresponding quarter previous year.
